Cargando…
Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey
INTRODUCTION: Pre-exposure prophylaxis (PrEP) is effective in reducing HIV transmission among key populations. In India, where PrEP is not currently part of the national HIV program, little is known about PrEP awareness, willingness to use PrEP, and barriers to uptake among people who inject drugs (...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906475/ https://www.ncbi.nlm.nih.gov/pubmed/33630909 http://dx.doi.org/10.1371/journal.pone.0247352 |
_version_ | 1783655296416088064 |
---|---|
author | Belludi, Ashwin McFall, Allison M. Solomon, Sunil Suhas Celentano, David D. Mehta, Shruti H. Srikrishnan, A. K. Kumar, M. Suresh Solomon, Suniti Lucas, Gregory M. |
author_facet | Belludi, Ashwin McFall, Allison M. Solomon, Sunil Suhas Celentano, David D. Mehta, Shruti H. Srikrishnan, A. K. Kumar, M. Suresh Solomon, Suniti Lucas, Gregory M. |
author_sort | Belludi, Ashwin |
collection | PubMed |
description | INTRODUCTION: Pre-exposure prophylaxis (PrEP) is effective in reducing HIV transmission among key populations. In India, where PrEP is not currently part of the national HIV program, little is known about PrEP awareness, willingness to use PrEP, and barriers to uptake among people who inject drugs (PWID) and men who have sex with men (MSM). METHODS: We used respondent-driven sampling to accrue PWID and MSM in 22 sites from August 2016 to May 2017. Participants were asked about awareness of PrEP, willingness to use PrEP (following a brief description) and reasons why they might not be willing to use PrEP. Participants were also queried on preferences for PrEP delivery modality (oral vs. injectable). Multi-level logistic regression models were used to determine participant correlates of willingness to use PrEP. Estimates were weighted for the sampling method. RESULTS: A total of 10,538 PWID and 8,621 MSM who self-reported being HIV-negative were included in the analysis. Only 6.1% (95% confidence interval [CI]: 5.9, 6.3) of PWID and 8.0% of MSM (95% CI: 7.7, 8.4) were aware of PrEP. However, willingness to use PrEP was substantially higher in both groups: 52.4% of PWID and 67.6% of MSM. Participants commonly cited a perceived low risk for acquiring HIV infection, being perceived by others as being HIV-positive, and side effects as reasons why they would be unwilling to use PrEP. Among PWID, sharing needles and hazardous alcohol use were associated with increased willingness to use PrEP. Among MSM, having a main male partner and injection drug use were associated with increased willingness to use PrEP. Preference for daily oral or monthly injectable PrEP was similar among MSM (39.6%% vs. 41.7%,), while PWID were more likely to prefer oral to injectable administration routes (56.3% vs. 31.1%). CONCLUSIONS: As India plans to roll-out of PrEP in the public sector, our multi-city survey of PWID and MSM highlights the need for key population-focused education campaigns about PrEP and self-assessment of risk. |
format | Online Article Text |
id | pubmed-7906475 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-79064752021-03-03 Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey Belludi, Ashwin McFall, Allison M. Solomon, Sunil Suhas Celentano, David D. Mehta, Shruti H. Srikrishnan, A. K. Kumar, M. Suresh Solomon, Suniti Lucas, Gregory M. PLoS One Research Article INTRODUCTION: Pre-exposure prophylaxis (PrEP) is effective in reducing HIV transmission among key populations. In India, where PrEP is not currently part of the national HIV program, little is known about PrEP awareness, willingness to use PrEP, and barriers to uptake among people who inject drugs (PWID) and men who have sex with men (MSM). METHODS: We used respondent-driven sampling to accrue PWID and MSM in 22 sites from August 2016 to May 2017. Participants were asked about awareness of PrEP, willingness to use PrEP (following a brief description) and reasons why they might not be willing to use PrEP. Participants were also queried on preferences for PrEP delivery modality (oral vs. injectable). Multi-level logistic regression models were used to determine participant correlates of willingness to use PrEP. Estimates were weighted for the sampling method. RESULTS: A total of 10,538 PWID and 8,621 MSM who self-reported being HIV-negative were included in the analysis. Only 6.1% (95% confidence interval [CI]: 5.9, 6.3) of PWID and 8.0% of MSM (95% CI: 7.7, 8.4) were aware of PrEP. However, willingness to use PrEP was substantially higher in both groups: 52.4% of PWID and 67.6% of MSM. Participants commonly cited a perceived low risk for acquiring HIV infection, being perceived by others as being HIV-positive, and side effects as reasons why they would be unwilling to use PrEP. Among PWID, sharing needles and hazardous alcohol use were associated with increased willingness to use PrEP. Among MSM, having a main male partner and injection drug use were associated with increased willingness to use PrEP. Preference for daily oral or monthly injectable PrEP was similar among MSM (39.6%% vs. 41.7%,), while PWID were more likely to prefer oral to injectable administration routes (56.3% vs. 31.1%). CONCLUSIONS: As India plans to roll-out of PrEP in the public sector, our multi-city survey of PWID and MSM highlights the need for key population-focused education campaigns about PrEP and self-assessment of risk. Public Library of Science 2021-02-25 /pmc/articles/PMC7906475/ /pubmed/33630909 http://dx.doi.org/10.1371/journal.pone.0247352 Text en © 2021 Belludi et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Belludi, Ashwin McFall, Allison M. Solomon, Sunil Suhas Celentano, David D. Mehta, Shruti H. Srikrishnan, A. K. Kumar, M. Suresh Solomon, Suniti Lucas, Gregory M. Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey |
title | Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey |
title_full | Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey |
title_fullStr | Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey |
title_full_unstemmed | Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey |
title_short | Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey |
title_sort | awareness of and willingness to use pre-exposure prophylaxis (prep) among people who inject drugs and men who have sex with men in india: results from a multi-city cross-sectional survey |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906475/ https://www.ncbi.nlm.nih.gov/pubmed/33630909 http://dx.doi.org/10.1371/journal.pone.0247352 |
work_keys_str_mv | AT belludiashwin awarenessofandwillingnesstousepreexposureprophylaxisprepamongpeoplewhoinjectdrugsandmenwhohavesexwithmeninindiaresultsfromamulticitycrosssectionalsurvey AT mcfallallisonm awarenessofandwillingnesstousepreexposureprophylaxisprepamongpeoplewhoinjectdrugsandmenwhohavesexwithmeninindiaresultsfromamulticitycrosssectionalsurvey AT solomonsunilsuhas awarenessofandwillingnesstousepreexposureprophylaxisprepamongpeoplewhoinjectdrugsandmenwhohavesexwithmeninindiaresultsfromamulticitycrosssectionalsurvey AT celentanodavidd awarenessofandwillingnesstousepreexposureprophylaxisprepamongpeoplewhoinjectdrugsandmenwhohavesexwithmeninindiaresultsfromamulticitycrosssectionalsurvey AT mehtashrutih awarenessofandwillingnesstousepreexposureprophylaxisprepamongpeoplewhoinjectdrugsandmenwhohavesexwithmeninindiaresultsfromamulticitycrosssectionalsurvey AT srikrishnanak awarenessofandwillingnesstousepreexposureprophylaxisprepamongpeoplewhoinjectdrugsandmenwhohavesexwithmeninindiaresultsfromamulticitycrosssectionalsurvey AT kumarmsuresh awarenessofandwillingnesstousepreexposureprophylaxisprepamongpeoplewhoinjectdrugsandmenwhohavesexwithmeninindiaresultsfromamulticitycrosssectionalsurvey AT solomonsuniti awarenessofandwillingnesstousepreexposureprophylaxisprepamongpeoplewhoinjectdrugsandmenwhohavesexwithmeninindiaresultsfromamulticitycrosssectionalsurvey AT lucasgregorym awarenessofandwillingnesstousepreexposureprophylaxisprepamongpeoplewhoinjectdrugsandmenwhohavesexwithmeninindiaresultsfromamulticitycrosssectionalsurvey |